Aviva PLC Novo Cure LTD Transaction History

Aviva PLC

$36.8 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$40.29 - $82.51 $4.65 Million - $9.51 Million	-115,318 Reduced 56.99%	87,041 $3.61 Million
Q1 2023 May 12, 2023	BUY	$56.44 - $118.81 $108,872 - $229,184	1,929 Added 0.96%	202,359 $12.2 Million
Q4 2022 Feb 09, 2023	BUY	$63.98 - $85.37 $7.73 Million - $10.3 Million	120,871 Added 151.93%	200,430 $14.7 Million
Q3 2022 Nov 14, 2022	SELL	$67.99 - $89.57 $2.01 Million - $2.64 Million	-29,516 Reduced 27.06%	79,559 $6.05 Million
Q2 2022 Aug 04, 2022	BUY	$56.6 - $89.9 $4.67 Million - $7.42 Million	82,524 Added 310.81%	109,075 $7.58 Million
Q1 2022 May 13, 2022	SELL	$60.15 - $84.52 $236,449 - $332,248	-3,931 Reduced 12.9%	26,551 $2.2 Million
Q4 2021 Feb 10, 2022	SELL	$75.08 - $121.99 $60,214 - $97,835	-802 Reduced 2.56%	30,482 $2.29 Million
Q3 2021 Nov 12, 2021	SELL	$116.17 - $194.55 $876,618 - $1.47 Million	-7,546 Reduced 19.43%	31,284 $3.63 Million
Q2 2021 Aug 10, 2021	SELL	$130.4 - $225.58 $631,396 - $1.09 Million	-4,842 Reduced 11.09%	38,830 $8.61 Million
Q1 2021 May 13, 2021	BUY	$124.11 - $190.17 $3.71 Million - $5.69 Million	29,930 Added 217.8%	43,672 $5.77 Million
Q4 2020 Feb 10, 2021	SELL	$112.16 - $174.14 $914,552 - $1.42 Million	-8,154 Reduced 37.24%	13,742 $2.38 Million
Q3 2020 Nov 12, 2020	SELL	$58.05 - $111.31 $1.03 Million - $1.97 Million	-17,685 Reduced 44.68%	21,896 $2.44 Million
Q2 2020 Aug 13, 2020	SELL	$57.2 - $74.41 $828,027 - $1.08 Million	-14,476 Reduced 26.78%	39,581 $2.35 Million
Q1 2020 May 14, 2020	BUY	$57.05 - $95.75 $3.08 Million - $5.18 Million	54,057 New	54,057 $3.64 Million

Others Institutions Holding NVCR

# of Institutions

263

Shares Held

77M

Call Options Held

1.17M

Put Options Held

318K

Black Rock Inc. New York, NY

12.1M
Shares

$374 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

11.8M
Shares

$365 Million
0.0% of portfolio
Capital International Investors Los Angeles, CA

7.92M
Shares

$244 Million
0.02% of portfolio
Capital World Investors Los Angeles, CA

4.31M
Shares

$133 Million
0.01% of portfolio
Nordwand Advisors, LLC Radnor, PA

3.03M
Shares

$93.3 Million
12.67% of portfolio

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.23B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviva PLC with notifications on news.

Account